Publications by authors named "Maria Riveiro"

Claim this Profile
F
From Predicting Cancer Treatment Response to Identifying Novel Therapeutic Targets using Graph Neural Networks.
Leila Outemzabet, Nicolas Gaud, Aurelie Bertaux, Christophe Nicolle, Stephane Gerart, Maria E Riveiro

IEEE J Biomed Health Inform· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of conventional versus 3D-printed cosmetic covers on user satisfaction and psychosocial well-being in lower limb prostheses users: A randomised crossover trial.
Nerrolyn Ramstrand, Maria Riveiro, Lars Eriksson, Michael Ceder

J Rehabil Assist Technol Eng· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers.
Filippo Spriano, Giulio Sartori, Jacopo Sgrignani, Laura Barnabei, Alberto J Arribas, Maria E Riveiro

Haematologica· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing feelings into lower-limb prostheses - A kansei engineering approach to understand lower-limb prosthetic cosmeses.
Nerrolyn Ramstrand, Maria Riveiro, Lars Eriksson, Michael Ceder

J Rehabil Assist Technol Eng· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Problem Space for Designing Visualizations.
Michael Gleicher, Maria Riveiro, Tatiana von Landesberger, Oliver Deussen, Remco Chang

IEEE Comput Graph Appl· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Interactive Visualization in Fostering Trust in AI.
Emma Beauxis-Aussalet, Michael Behrisch, Rita Borgo, Duen Horng Chau, Christopher Collins, Maria Riveiro

IEEE Comput Graph Appl· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile.
Simona Sestito, Andrea Bacci, Sara Chiarugi, Massimiliano Runfola, Francesca Gado, Maria E Riveiro

Eur J Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the Tyrosine Phosphatase SHP-2 in Mediating Adrenomedullin Proangiogenic Activity in Solid Tumors.
Romain Sigaud, Nadège Dussault, Caroline Berenguer-Daizé, Christine Vellutini, Zohra Benyahia, Maria E Riveiro

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensor Fusion and Convolutional Neural Networks for Indoor Occupancy Prediction Using Multiple Low-Cost Low-Resolution Heat Sensor Data.
Simon Arvidsson, Marcus Gullstrand, Beril Sirmacek, Maria Riveiro

Sensors (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-assignment clustering: Machine learning from a biological perspective.
Benjamin Ulfenborg, Alexander Karlsson, Maria Riveiro, Christian X Andersson, Peter Sartipy

J Biotechnol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.
Ramiro Vázquez, Maria E Riveiro, Caroline Berenguer-Daizé, Anthony O'Kane, Julie Gormley

Front Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occupancy Prediction Using Low-Cost and Low-Resolution Heat Sensors for Smart Offices.
Beril Sirmacek, Maria Riveiro

Sensors (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.
Lucile Astorgues-Xerri, Ramiro Vázquez, Elodie Odore, Keyvan Rezai, Carmen Kahatt, María E Riveiro

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer.
Gianluca Civenni, Roberto Bosotti, Andrea Timpanaro, Ramiro Vàzquez, Jessica Merulla, Maria E Riveiro

Cell Metab· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fighter pilots' teamwork: a descriptive study.
Ulrika Ohlander, Jens Alfredson, Maria Riveiro, Göran Falkman

Ergonomics· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma.
Afua A Mensah, Luciano Cascione, Eugenio Gaudio, Chiara Tarantelli, Riccardo Bomben, Maria E Riveiro

Haematologica· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.
Chiara Tarantelli, Elena Bernasconi, Eugenio Gaudio, Luciano Cascione, Valentina Restelli, Maria E Riveiro

ESMO Open· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A data analysis framework for biomedical big data: Application on mesoderm differentiation of human pluripotent stem cells.
Benjamin Ulfenborg, Alexander Karlsson, Maria Riveiro, Caroline Améen, Karolina Åkesson

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.
Ramiro Vázquez, Simonetta Andrea Licandro, Lucile Astorgues-Xerri, Emanuele Lettera, Nicolò Panini, María Eugenia Riveiro

Int J Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Ramiro Vázquez, María E Riveiro, Lucile Astorgues-Xerri, Elodie Odore, Keyvan Rezai

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations.
Maria E Riveiro, Lucile Astorgues-Xerri, Ramiro Vazquez, Roberta Frapolli, Ivo Kwee

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
Caroline Berenguer-Daizé, Lucile Astorgues-Xerri, Elodie Odore, Mylène Cayol, Esteban Cvitkovic, Maria E Riveiro

Int J Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.
Michela Boi, Maria Todaro, Valentina Vurchio, Shao Ning Yang, John Moon, Maria E Riveiro

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.
Maria Serova, Annemilaï Tijeras-Raballand, Celia Dos Santos, Matthieu Martinet, Cindy Neuzillet, Maria Eugenia Riveiro

Oncotarget· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.
Anton Henssen, Kristina Althoff, Andrea Odersky, Anneleen Beckers, Richard Koche, Maria E Riveiro

Clin Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis